The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
Global Vaccine Market is projected to reach US$ 70 Billion by the year 2024. The vaccine market is likely to witness a significant growth throughout the forecast period due to the growing prevalence of diseases, increasing government and non-government funding for vaccine development & distribution and increasing investments by companies to develop new vaccines. Furthermore, growing demand for preventive vaccines, rising consciousness about vaccination coupled with mounting demand from the emerging countries is expected to boost the global vaccine businesses in the near future.
The vaccine is a safe and effective biological preparation, which improves the immunity against a particular disease. Technological advancement, rising demand for low cost products and widespread routine immunization programmes in several countries around the world will certainly expect to stimulate the growth of the vaccine market in the following years. Also, rising demand for combinations vaccines as it provides immunization against several diseases in a single shot is further expected to boost the vaccine business growth.
Renub Research report titled “Global Vaccine Market, People Vaccinated, Vaccines Administered, Immunization, By Disease [Influenza, Cervical Cancer, Zoster (Shingles), MMR (Measles, Mumps, and Rubella), Pneumonia, Meningitis, Hepatitis, Tap (Diphtheria, Tetanus, Pertussis), Haemophilus influenzae type B (Hib), Polio, Rotavirus, Varicella, Combination Vaccine, Travel & Miscellaneous Vaccine], By End User [Infants (Pediatric), & Adult], Companies (GlaxoSmithKline, Merck, Sanofi, Pfizer, & Others)” provides a complete analysis of Global Vaccine Market.
By Disease - Pneumococcal Vaccine is likely to grow at noteworthy rate over the coming years
The report studies the market of the following vaccine: Influenza, Cervical Cancer, Zoster (Shingles), MMR (Measles, Mumps, and Rubella), Pneumonia, Meningitis, Hepatitis, Tap (Diphtheria, Tetanus, Pertussis), Haemophilus influenzae type B (Hib), Polio, Rotavirus, Varicella, Combination Vaccine, Travel & Miscellaneous Vaccine. Influenza, Pneumococcal, Meningococcal, Hepatitis and Combination Vaccines together hold the significant market share and is expected to continue so.
By End User – Infants (Pediatric) Segment leads the Global Vaccine Market
The report studies the market by end user as Infants (Pediatric) and Adults. It is found that the market for Infants (Pediatric) segment is huge because as most of the countries now have included a series of vaccines to their National Immunization Programme as the per WHO recommendations. For the year 2017; Combos (Combination Vaccines) has the maximum immunization share among all pediatric vaccines (Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Haemophilus Influenzae Type b(Hib), Polio, Rotavirus, Varicella) studied in the report as they protect against more ailments in single shot, people preferring to get combination vaccine instead of a specific vaccine.
GlaxoSmithKline, Merck, Sanofi, and Pfizer are some of the top companies that deal efficiently in vaccine business globally. These companies have been studied thoroughly in the report.
Administration of Vaccine Doses
Our analysis found that there is a consistent surge in the number of Pneumococcal and Meningococcal vaccine doses administration in future due to the rising concern against the life-threatening vaccine-preventable diseases around the world.
- Cervical Cancer
- Zoster (Shingles)
- MMR (Measles, Mumps, and Rubella)
- Tap (Diphtheria, Tetanus, Pertussis)
- Haemophilus influenzae type B
- Combination Vaccine
- Travel & Miscellaneous Vaccine
By End User:
- Infants (Pediatric)
Key Companies Covered in the Report:
Global Vaccine Market has been extensively studied from 3 major points, and further sub-divided into 2 more points:
1. World Vaccines (Disease wise) Market & Forecast
a. Adult Vaccines Market
b. Pediatrics Vaccines Market
2. Number of Vaccinated People (Disease wise) & Forecast
a. Number of Vaccinated Adult
b. Number of Vaccinated Infants (Pediatric)
3. Doses of Vaccines Administered (Disease wise) & Forecast
a. Doses of vaccines administered in Adults
b. Doses of vaccines administered in Infants (Pediatric)